- 现金
- 2552 元
- 精华
- 8
- 帖子
- 1647
- 注册时间
- 2008-7-14
- 最后登录
- 2019-1-15
|
Results: Interim data has shown that all patients treated to date have cleared
HBsAg and developed protective immunity. Clearance of HBsAg and
development of protective levels of anti-HBs occurred as early as 7 days following
initiation of treatment at higher doses.At the time of abstract submission,
one patient has already exhibited clear signs of a sustained virologic response
(HBV DNA -, HBsAg -, HBeAg -, anti-HBs +, anti-HBe +) for 8 continuous
weeks off treatment after receiving only 23 weeks of treatment with REP9AC.
Conclusions: These results demonstrate that amphipathic polymers are effective
in rapidly reducing HBsAg levels in CHB patients which allows patients to
seroconvert. The rapid appearance of anti-HBs and anti-HBe antibodies in these
patients, the best predictors of SVR in patients with CHB, suggest that amphipathic
polymers could become an important new tool in the treatment of CHB.
======================================================
前面的内容已经他说了所有的病人已经清除了表抗原和产生表抗体了。。那为什么后面又说投稿前有一个已经产生持续性的病毒学应答?(乙肝病毒脱氧核糖核酸 - 乙肝表面抗原 - e抗原 - 抗- HBs +,抗- HBe +)到底是所有的都消除了表抗和产生抗体了还是就一个?
[ 本帖最后由 fromdesert34 于 2010-4-5 18:14 编辑 ] |
|